Hamlet Pharma Investor Relations Material
Hamlet Pharma AB, a pharmaceutical company, engages in the research and development of cancer drugs. The company's lead product candidate is a patented drug that combines the active ingredient Bisantrene-Guanidinylpenicillamine in a galenic form suitable for oral administration. Its BAR treatment is administered through small pills that slowly release the active ingredient into the upper part of the gastrointestinal tract. The company is headquartered in Malmö, Sweden
Upcoming events for
Q3 20222022-11-11
Q2 20222022-08-26
Latest company events
Ticker symbol
HAMLET
Country
Sweden
About the company
Investor Relations Page
Dig deeper into the Hamlet Pharma fundamentals on Quartr.
- Skip straight to the Q&A session
- Receive notifications about new events
- Connect the financial calender on your phone
- Figure out why the stock is up or down
- Read the transcripts or scroll the deck
- Access earnings or press releases
